Schedule 13G ownership disclosure

X4 PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98420X103

Event date: 2020-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-329940
Form type
SC 13G
Filer
Ikarian Capital, LLC
CIK
CIK 1778253
Filed
Dec 30, 2020
Reporting period
Dec 29, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub